Company: INKT
Filing Date: 2025-04-18
Form Type: PRE 14A
Source: 0000950170-25-055881
Chunk: 25

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-04-18
Form: PRE 14A
Chunk 25
---
Change of Control Policy.On June 8, 2022, the Board approved our Executive Change of Control Plan and form of Participation Agreement (together, the “CIC Plan”) pursuant to which certain of our employees at the level of vice president or above are eligible to participate, including Dr. Buell. The terms “cause,” “good reason,” and “change of control” referred to below are defined in the CIC Policy.

<div align='center'>17</div>

Under the terms of the CIC Plan, if a change of control occurs and the executive is employed by the Company on the date of such change of control, then 50% of any stock options, restricted stock units or shares of restricted stock of the Company previously granted or issued to the executive that are outstanding and unvested as of the date of the change of control and for which vesting is solely based on the passage of time shall become vested, exercisable and, in the case of shares of restricted stock, no longer subject to forfeiture.

The CIC Plan provides for certain payments and benefits upon termination of employment following a change of control. Under the terms of the CIC Plan, if a change of control occurs and the Company terminates the applicable executive’s employment other than for cause or the executive terminates his or her employment for good reason within eighteen (18) months following a change of control, the executive will be entitled to the following:

a lump sum payment equal to the sum of: (a) the executive’s base salary in effect on the date of termination (or, if greater, as in effect prior to any reduction to such base salary following the change of control), plus an amount equal to the higher of (A) the executive’s target incentive bonus for the year in which the executive’s employment terminates (or, if greater, as in effect prior to any reduction to such target incentive bonus following the change of control), or (B) the actual incentive bonus paid to the executive, if any, under the Company’s incentive plan for the last full fiscal year preceding the year in which the executive’s employment terminates;

if the executive timely elects COBRA continuation coverage, the Company shall also pay the employer portion of the group medical and dental premium payments as in effect on the date of the termination of employment for the executive and his or her qualified dependents until the earlier of (i) the end of the twelve (12)-month period following the date of termination of employment, or (ii) the date on which the